Latest Breaking News On - வெப்பமண்டல மருந்து நிறுவனம் - Page 1 : comparemela.com

Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba. By Niurka Molina-Águila,Elba Cruz-Rodríguez,Rita M Ferrán-Torres,Belkys M Galindo-Santana,Yanaris López-Almaguer,Manuel Romero-Placeres May 13, 2021 COVID-19 is caused by the novel coronavirus SARS-CoV-2 and was declared a pandemic on March 11, 2020, the same day that the first cases in Cuba were diagnosed. In Cuba, all confirmed cases of COVID-19 were hospitalized from this point forward. Characterize the first patients diagnosed with COVID-19 in Cuba. METHODS We carried out a descriptive, cross-sectional study of 415 suspected cases of COVID-19 admitted to the Pedro Kourí Tropical Medicine Institute in Havana, Cuba, from March 11, 2020 through April 10, 2020. (In Cuba, all patients suspected of being COVID-19-positive were admitted to hospitals or isolation centers for observation and treatment.) Of these 415 individuals, 63 (15.2%) tested positive for SARS-CoV-2. Information

Ciudad de la habanaPedro kourTropical medicine instituteயடட டி லா ஹபனாபேடரோ கோர்வெப்பமண்டல மருந்து நிறுவனம்